Devia Emerges From Stealth With AI Agents for Pharmaceutical Quality Investigations

Devia launched from stealth with AI agents designed to help pharmaceutical companies conduct quality investigations, aiming to explain failures, identify root causes, document responses, and detect recurring problems.

Read the full story at Unite.AI ↗

Timeline · 1 report

2026-11-11 07:00 · Unite.AI
Devia Emerges From Stealth With AI Agents for Pharmaceutical Quality Investigations

More stories

Anthropic IPO expected to begin trading Nov. 19 at $1.4 trillion valuation — CNBC Technology
Nvidia CEO Jensen Huang faces spy scandal and scrutiny over China AI chip access — New York Times AI
DeepSeek's Harness agent app reaches 1.54 million daily users — Bloomberg AI
OpenAI Acquires AI Travel Startup Odessia — The Information AI
STATERA Library expands robotics drive and connector engineering documentation — DEV Community — AI
Google's Gemini 4 Carbon model rolls out across Copilot, API, and agent tools — Google DeepMind Blog
Cognizant Launches Claude Managed Services With 25,000-Strong Frontier Capability Group — Economic Times Tech
OpenAI launches Businesses in ChatGPT in beta with claimable profiles and Business Agents — OpenAI News

Get the daily brief of stories like this at 6:30 every morning →